Seventh clot case involving Johnson & Johnson COVID-19 vaccine revealed
Fox News
A Centers for Disease Control and Prevention (CDC) committee learned Wednesday of a seventh woman who developed a rare and severe type of blood clot after receiving the J&JCOVID-19 vaccine, and a man whose occurred during clinical trial, but it could not be linked to the jab at the time.
The Advisory Committee on Immunization Practices (ACIP) had met to discuss whether there was enough available information to make interim age or risk factor-based recommendations regarding the vaccine, and what recommendation the committee felt is appropriate given currently available information for use of the one-dose shot. The meeting was held one day after the FDA and CDC recommended a pause in the Johnson & Johnson COVID-19 vaccine rollout.More Related News